MedVellum
MedVellum
Back to Library
Paediatrics
Endocrinology
Neonatology
EMERGENCY

Congenital Adrenal Hyperplasia (CAH)

High EvidenceUpdated: 2025-12-24

On This Page

Red Flags

  • Salt-wasting crisis (neonatal shock, hyponatraemia, hyperkalaemia)
  • Ambiguous genitalia (virilised female, undervirilised male)
  • Adrenal crisis on illness or stress
  • Unexplained neonatal death in sibling
  • Failure to thrive with electrolyte disturbance
Overview

Congenital Adrenal Hyperplasia (CAH)

1. Clinical Overview

Summary

Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting adrenal steroidogenesis. The vast majority (~95%) are caused by 21-hydroxylase deficiency (21-OHD), which impairs cortisol and aldosterone synthesis while shunting precursors towards androgen production. The clinical spectrum ranges from the severe "classic" forms (salt-wasting and simple virilising) to the milder "non-classic" form. Classic salt-wasting CAH presents in the first 1-2 weeks of life with life-threatening adrenal crisis (hyponatraemia, hyperkalaemia, shock) and virilisation of female genitalia. Early diagnosis through newborn screening programmes and prompt treatment with glucocorticoid and mineralocorticoid replacement is life-saving. Non-classic CAH presents later with signs of androgen excess (hirsutism, acne, oligomenorrhoea).

Key Facts

  • Inheritance: Autosomal recessive; carrier frequency ~1:50 in general population
  • Enzyme defect: 21-hydroxylase (CYP21A2) — 95% of CAH
  • Pathophysiology: Low cortisol → High ACTH → Adrenal hyperplasia → Excess androgens
  • Classic salt-wasting (~75%): Aldosterone + cortisol deficiency; adrenal crisis at 1-2 weeks
  • Classic simple virilising (~25%): Cortisol deficiency; excess androgens; no salt-wasting
  • Non-classic (late-onset): Mild; androgen excess symptoms; often diagnosed in adolescence/adulthood
  • Diagnosis: Elevated 17-hydroxyprogesterone (17-OHP) — blood spot screening
  • Treatment: Hydrocortisone + Fludrocortisone (salt-wasters); stress dosing during illness
  • Virilisation: Female neonates have ambiguous genitalia (clitoromegaly, labial fusion); males may be undetected until crisis

Clinical Pearls

"A Sick Neonate at 1-2 Weeks = Think CAH": Classic salt-wasting CAH presents around day 7-14 with poor feeding, vomiting, lethargy, and shock. Hyponatraemia + hyperkalaemia should trigger urgent investigation.

"Female with Ambiguous Genitalia = CAH Until Proven Otherwise": Virilised female genitalia (clitoromegaly, fused labia but absent gonads) is the hallmark presentation. The baby is 46,XX but appears masculinised.

"17-OHP Is the Diagnostic Test": Elevated 17-hydroxyprogesterone (17-OHP) confirms 21-hydroxylase deficiency. Newborn screening picks up most cases in screened populations.

"Stress Dosing Saves Lives": Patients with CAH need doubled or tripled hydrocortisone doses during illness/stress. Parents must be educated on emergency management and given IM hydrocortisone for emergencies.

"Boys Present Later or Not at All": Male infants may not show virilisation (they're already male) and can present later with precocious puberty or in life-threatening crisis. Salt-wasting crisis is often the first sign.

Why This Matters Clinically

CAH is a medical emergency in neonates. Undiagnosed salt-wasting CAH is fatal. Early recognition, newborn screening, and lifelong hormone replacement prevent adrenal crises and optimise growth and development. All clinicians should be able to recognise and initiate emergency treatment for adrenal crisis.[1,2]


2. Epidemiology

Incidence & Prevalence

ParameterData
Classic CAH incidence~1:15,000 live births
Non-classic CAH~1:1,000 (more common; often undiagnosed)
Carrier frequency (21-OHD)~1:50
Higher incidenceAshkenazi Jewish, Alaskan Yupik populations

Forms of CAH

FormSeverityFeaturesPrevalence
Classic Salt-WastingSevereCortisol + Aldosterone deficiency; virilisation~75% of classic
Classic Simple VirilisingModerateCortisol deficiency; virilisation; no salt-wasting~25% of classic
Non-Classic (Late-Onset)MildAndrogen excess only; no cortisol/aldosterone deficiency1:1,000

3. Pathophysiology

Steroidogenesis Pathway

Normal Pathway:

  • Cholesterol → Pregnenolone → 17-OH Pregnenolone → 17-OHP → 11-Deoxycortisol → Cortisol
  • Aldosterone: Cholesterol → Pregnenolone → Progesterone → DOC → Corticosterone → Aldosterone

21-Hydroxylase Deficiency:

  • Blocks conversion of 17-OHP → 11-Deoxycortisol (cortisol pathway)
  • Blocks conversion of Progesterone → DOC (aldosterone pathway)
  • Result: Precursors (17-OHP, Progesterone) accumulate and shunt to androgen pathway
  • ACTH drive increases (low cortisol feedback) → Adrenal hyperplasia

Consequences of Enzyme Block

ConsequenceMechanismClinical Effect
Low CortisolBlocked synthesisAdrenal insufficiency; hypoglycaemia; poor stress response
Low AldosteroneBlocked synthesis (salt-wasting form)Hyponatraemia, Hyperkalaemia, Volume depletion, Shock
High AndrogensShunted precursorsVirilisation (female genitalia); precocious puberty
Adrenal HyperplasiaHigh ACTH driveBilateral adrenal enlargement

Genetic Basis

GeneChromosomeNotes
CYP21A26p2121-hydroxylase; most common
Pseudogene (CYP21A1P)AdjacentGene conversion/deletion causes disease
Mutation severityCorrelates with phenotypeComplete loss = salt-wasting; partial = simple virilising

4. Clinical Presentation

Classic Salt-Wasting CAH (Neonates)

Timeline: Presents around day 7-14 of life (after maternal hormones clear)

FeatureDetails
Virilised female genitaliaClitoromegaly; labial fusion; urogenital sinus; 46,XX but appears male; gonads NOT palpable
Male neonatesNormal genitalia; may have subtle hyperpigmentation of scrotum
Salt-wasting crisisPoor feeding, vomiting, lethargy, weight loss, dehydration, shock
ElectrolytesHyponatraemia, Hyperkalaemia, Metabolic acidosis
HypoglycaemiaDue to cortisol deficiency
HyperpigmentationDue to high ACTH (stimulates melanocytes)

Classic Simple Virilising CAH

FeatureDetails
FemalesAmbiguous genitalia at birth
MalesNormal genitalia; may present later with precocious puberty (early pubic hair, phallic enlargement, advanced bone age)
No salt-wastingAldosterone production is preserved

Non-Classic (Late-Onset) CAH

FeatureFemalesMales
PresentationHirsutism, acne, oligomenorrhoea, infertilityOften asymptomatic or mild acne
Age at diagnosisAdolescence/adulthoodOften undiagnosed
No virilisation at birth——
MimicsPCOS—

Red Flags — Emergency Recognition

[!CAUTION] Adrenal Crisis — Life-Threatening:

  • Neonate with poor feeding, vomiting, lethargy at 1-2 weeks
  • Hyponatraemia (<130 mmol/L) + Hyperkalaemia (>6 mmol/L)
  • Shock, circulatory collapse
  • Hypoglycaemia
  • Any neonate with ambiguous genitalia

5. Clinical Examination

Neonatal Examination

General:

  • Lethargy or irritability
  • Dehydration (skin turgor, sunken fontanelle, dry mucous membranes)
  • Hyperpigmentation (nipples, genitalia)

Genitalia — Female (46,XX):

FindingPrader Stage
Normal femaleStage 0
Clitoromegaly onlyStage 1
Clitoromegaly + partial labial fusionStage 2
Single urogenital opening (urogenital sinus)Stage 3
Complete labial fusion; phallic structureStage 4
Male-appearing; gonads not palpableStage 5

Key Point: Gonads are NOT palpable in virilised 46,XX females (ovaries are intra-abdominal). In a "male" with undescended testes and hypospadias, consider CAH.

Genitalia — Male:

  • Usually normal at birth
  • May have scrotal hyperpigmentation
  • May present later with precocious puberty

6. Investigations

Urgent Investigations (Suspected Adrenal Crisis)

TestExpected Finding
Electrolytes (U&E)Hyponatraemia (<130); Hyperkalaemia (>6)
GlucoseHypoglycaemia
Blood gasMetabolic acidosis
CortisolLow (usually <100 nmol/L)
17-OHPMarkedly elevated (>300 nmol/L in classic)
ACTHElevated
ReninElevated (in salt-wasting)
AldosteroneLow (salt-wasting)

Newborn Screening

TestMethodNotes
17-OHP blood spotHeel prick (day 5)Part of UK Newborn Bloodspot Screening Programme
Positive screenConfirmatory serum 17-OHP + genetic testing

Confirmatory Tests

TestPurpose
Serum 17-OHPElevated in 21-OHD
Synacthen (ACTH stimulation) testIf diagnosis unclear; 17-OHP response
Genetic testing (CYP21A2)Confirms mutation; prenatal genetic counselling
KaryotypeEstablish genetic sex in ambiguous genitalia

Additional Investigations

InvestigationIndication
Pelvic ultrasoundVisualise uterus/ovaries in ambiguous genitalia
Bone age X-rayIf precocious puberty (advanced bone age)
Adrenal imagingEnlarged adrenals on ultrasound

7. Management

Management Algorithm

           CAH MANAGEMENT ALGORITHM
                     ↓
┌────────────────────────────────────────────────────────────┐
│              ACUTE ADRENAL CRISIS                           │
├────────────────────────────────────────────────────────────┤
│  ⚠️ MEDICAL EMERGENCY — DO NOT DELAY                        │
│                                                             │
│  1. IV Access + Fluid Resuscitation:                        │
│     ➤ 0.9% Saline 20 mL/kg bolus; repeat if shocked        │
│     ➤ Correct hyponatraemia gradually                      │
│                                                             │
│  2. IV Hydrocortisone:                                       │
│     ➤ Neonate: 25 mg IV stat                               │
│     ➤ Infant: 25-50 mg IV stat                             │
│     ➤ Child: 50-100 mg IV stat                             │
│     Then 25-50 mg/m²/day divided q6h                       │
│                                                             │
│  3. Correct Hypoglycaemia:                                   │
│     ➤ 10% Dextrose 2 mL/kg bolus if hypoglycaemic          │
│                                                             │
│  4. Correct Hyperkalaemia:                                   │
│     ➤ Insulin-dextrose; calcium gluconate if ECG changes   │
│                                                             │
│  5. Monitor:                                                 │
│     ➤ Electrolytes q4-6h until stable                      │
│     ➤ Blood glucose                                        │
│     ➤ Urine output                                         │
└────────────────────────────────────────────────────────────┘
                     ↓
┌────────────────────────────────────────────────────────────┐
│              MAINTENANCE THERAPY                             │
├────────────────────────────────────────────────────────────┤
│  GLUCOCORTICOID REPLACEMENT:                                 │
│  ➤ Hydrocortisone 10-15 mg/m²/day in 3 divided doses       │
│  ➤ Given TDS (morning, afternoon, evening)                 │
│  ➤ Lowest effective dose to suppress androgens without     │
│    causing Cushing's features or growth suppression        │
│                                                             │
│  MINERALOCORTICOID REPLACEMENT (Salt-Wasters):               │
│  ➤ Fludrocortisone 50-200 mcg/day (usually 100-150 mcg)    │
│  ➤ Salt supplementation in infants (1-2 g NaCl/day)        │
│                                                             │
│  MONITORING:                                                 │
│  ➤ Growth (height, weight) — quarterly                     │
│  ➤ Blood pressure — mineralocorticoid excess               │
│  ➤ 17-OHP, Androstenedione levels                          │
│  ➤ Plasma renin (salt-wasters — aim high-normal)           │
│  ➤ Bone age annually                                       │
│  ➤ Sodium (especially in infancy)                          │
└────────────────────────────────────────────────────────────┘
                     ↓
┌────────────────────────────────────────────────────────────┐
│               STRESS DOSING                                  │
├────────────────────────────────────────────────────────────┤
│  ILLNESS RULES:                                              │
│  ➤ Minor illness (fever, viral): Double hydrocortisone     │
│  ➤ Moderate illness (gastroenteritis, vomiting): Triple    │
│  ➤ Vomiting/unable to take oral: IM Hydrocortisone         │
│                                                             │
│  EMERGENCY IM HYDROCORTISONE:                                │
│  ➤ &lt;1 year: 25 mg IM                                       │
│  ➤ 1-5 years: 50 mg IM                                     │
│  ➤ 6+ years / Adult: 100 mg IM                             │
│                                                             │
│  SURGERY:                                                    │
│  ➤ IV Hydrocortisone: Double dose pre-op + during         │
│  ➤ Post-op: Taper slowly to maintenance                    │
│                                                             │
│  PARENT EDUCATION:                                           │
│  ➤ Steroid emergency card / MedicAlert                     │
│  ➤ Training for IM hydrocortisone injection                │
│  ➤ Never stop steroids suddenly                            │
└────────────────────────────────────────────────────────────┘
                     ↓
┌────────────────────────────────────────────────────────────┐
│         SURGICAL MANAGEMENT (Feminising Genitoplasty)       │
├────────────────────────────────────────────────────────────┤
│  ➤ Controversial and evolving                              │
│  ➤ May include clitoroplasty, vaginoplasty, labioplasty   │
│  ➤ Timing debated: Infancy vs patient-determined          │
│  ➤ MDT decision with specialised DSD team                  │
│  ➤ Psychological support essential                         │
│  ➤ Informed consent / patient involvement when possible   │
└────────────────────────────────────────────────────────────┘

Medication Summary

MedicationDosePurpose
Hydrocortisone10-15 mg/m²/day TDSGlucocorticoid replacement
Fludrocortisone50-200 mcg/day (usually 100-150 mcg)Mineralocorticoid (salt-wasters)
Sodium chloride1-2 g/day (infants)Salt supplementation

8. Complications

Acute Complications

ComplicationManagement
Adrenal crisisIV fluids, IV hydrocortisone, electrolyte correction
HypoglycaemiaDextrose; avoid in future with stress dosing
DeathCan occur if undiagnosed/untreated

Long-Term Complications

ComplicationNotes
Short statureOver-treatment with glucocorticoids OR advanced bone age from androgen excess
ObesityGlucocorticoid excess
Testicular adrenal rest tumours (TARTs)Ectopic adrenal tissue in testes; monitor with ultrasound
Ovarian adrenal rest tumoursRare; may affect fertility
InfertilityDue to adrenal rest tumours, irregular menses (women), poor compliance
Psychological issuesEspecially related to DSD and genital surgery

9. Prognosis & Outcomes

With Treatment

OutcomeNotes
SurvivalExcellent with newborn screening and treatment
HeightOften below mid-parental height; depends on treatment optimisation
FertilityGenerally preserved with good control; TARTs affect male fertility
Quality of lifeCan be excellent; requires lifelong medication and monitoring

Without Treatment

OutcomeNotes
Salt-wasting CAHFatal without treatment (adrenal crisis)
Simple virilising CAHPrecocious puberty; short adult stature due to early epiphyseal fusion

10. Evidence & Guidelines

Key Guidelines

GuidelineOrganisationYearKey Points
Endocrine Society Clinical Practice Guideline — CAHEndocrine Society2018Diagnosis, management, monitoring
UK Newborn Screening ProgrammePHE / NHSOngoingCAH included in heel prick screen

Key Evidence

Newborn Screening Impact

  • Introduction of newborn screening has virtually eliminated deaths from salt-wasting CAH in screened populations
  • Early detection allows treatment before crisis

11. Patient/Layperson Explanation

What is Congenital Adrenal Hyperplasia (CAH)?

CAH is a genetic condition affecting the adrenal glands — small glands above the kidneys that make important hormones. In CAH, the adrenal glands can't make enough of the hormone cortisol, and sometimes aldosterone. This causes the body to make too many male hormones (androgens).

How does it affect babies?

Salt-wasting CAH (most common form):

  • Babies can become very unwell in the first 1-2 weeks with vomiting, poor feeding, and dehydration
  • This is a medical emergency and needs urgent treatment

Genital differences:

  • Baby girls may have genitals that look different (somewhere between male and female) because of too many male hormones
  • Baby boys often look normal but can become very sick

How is it treated?

  • Hormone replacement: Daily tablets (hydrocortisone to replace cortisol; fludrocortisone to replace aldosterone)
  • Salt supplements: Especially for babies
  • Sick day rules: Extra doses when unwell
  • Emergency injection: Parents are trained to give an injection if the child is vomiting or very unwell

Will my child lead a normal life?

With proper treatment and monitoring, children with CAH grow up to lead healthy, active lives. They need to take medication every day and carry emergency medication.


12. References

Guidelines

  1. Speiser PW, Arlt W, Auchus RJ, et al. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(11):4043-4088. PMID: 30272171

Key Studies

  1. Claahsen-van der Grinten HL, Stikkelbroeck NMML, Sweep FCGJ, et al. Fertility in patients with congenital adrenal hyperplasia. J Pediatr Endocrinol Metab. 2006;19(5):677-685.

13. Examination Focus

High-Yield Exam Topics

TopicKey Points
21-hydroxylase deficiency95% of CAH; blocks cortisol + aldosterone synthesis
Salt-wasting crisisWeek 1-2; hyponatraemia, hyperkalaemia, shock
17-OHPDiagnostic marker; elevated in 21-OHD
Virilised female46,XX with ambiguous genitalia; gonads NOT palpable
TreatmentHydrocortisone + Fludrocortisone; stress dosing
Stress dosingDouble dose for illness; IM hydrocortisone for vomiting

Sample Viva Questions

Q1: A 10-day-old baby presents with poor feeding, vomiting, and lethargy. Sodium is 120 mmol/L and potassium is 7.2 mmol/L. What is your differential and management?

Model Answer: This presentation is highly suspicious for salt-wasting congenital adrenal hyperplasia (21-hydroxylase deficiency). The combination of hyponatraemia, hyperkalaemia, and shock in a neonate at 1-2 weeks is classic. Immediate management: IV access, 0.9% saline bolus 20 mL/kg, IV hydrocortisone 25 mg stat, treat hyperkalaemia (calcium gluconate if ECG changes, insulin-dextrose), check glucose. Investigations: 17-OHP (will be markedly elevated), cortisol, ACTH, renin, aldosterone, blood gas, glucose. Examine genitalia (virilised female?). This is a medical emergency — do not delay treatment waiting for results. Confirmatory: Genetic testing CYP21A2.

Q2: How do you differentiate salt-wasting from simple virilising CAH?

Model Answer: Both forms have cortisol deficiency and androgen excess. The difference is aldosterone:

  • Salt-wasting (~75%): Also has aldosterone deficiency; presents with adrenal crisis (hyponatraemia, hyperkalaemia, shock) in first 1-2 weeks; requires fludrocortisone replacement
  • Simple virilising (~25%): Aldosterone production is preserved; no salt-wasting crisis; presents with virilisation at birth (females) or precocious puberty (males) Clinically, check plasma renin and aldosterone. Salt-wasters have elevated renin and low aldosterone.

Q3: What are the sick-day rules for a child with CAH?

Model Answer: During illness or stress, cortisol requirements increase. Sick-day rules:

  • Minor illness (fever, cold): Double the hydrocortisone dose
  • Moderate illness (gastroenteritis, high fever): Triple the hydrocortisone dose
  • Vomiting or unable to take oral medication: IM hydrocortisone immediately (25 mg <1 yr; 50 mg 1-5 yrs; 100 mg >6 yrs/adult) and seek medical attention
  • Surgery/major procedure: IV hydrocortisone cover perioperatively

Parents must be trained to give IM injections and have emergency hydrocortisone at home. Child should wear a MedicAlert bracelet.

Common Exam Errors

ErrorCorrect Approach
Not recognising sick neonate as CAHHyponatraemia + hyperkalaemia at week 1-2 = CAH
Forgetting 17-OHP17-OHP is the key diagnostic marker
Not knowing stress dosingDouble/triple dose during illness; IM if vomiting
Thinking virilised "male" has testesIn 46,XX virilisation, gonads are NOT palpable (ovaries intra-abdominal)

Last Reviewed: 2025-12-24 | MedVellum Editorial Team


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists.

Last updated: 2025-12-24

At a Glance

EvidenceHigh
Last Updated2025-12-24
Emergency Protocol

Red Flags

  • Salt-wasting crisis (neonatal shock, hyponatraemia, hyperkalaemia)
  • Ambiguous genitalia (virilised female, undervirilised male)
  • Adrenal crisis on illness or stress
  • Unexplained neonatal death in sibling
  • Failure to thrive with electrolyte disturbance

Clinical Pearls

  • **"17-OHP Is the Diagnostic Test"**: Elevated 17-hydroxyprogesterone (17-OHP) confirms 21-hydroxylase deficiency. Newborn screening picks up most cases in screened populations.
  • **Adrenal Crisis — Life-Threatening:**
  • - Neonate with poor feeding, vomiting, lethargy at 1-2 weeks
  • - Hyponatraemia (&lt;130 mmol/L) + Hyperkalaemia (&gt;6 mmol/L)
  • - Shock, circulatory collapse

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines